Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Schizophrenia

Free Subscription Articles published in Br J Psychiatry Retrieve available abstracts of 87 articles: HTML format

Single Articles

January 2021
1. CHAN JKN, Wong CSM, Or PCF, Chen EYH, et al
   Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study.
   Br J Psychiatry. 2021 Jan 7:1-8. doi: 10.1192/bjp.2020.
   PubMed     Abstract available
   
   
   December 2020
2. JIN H, Tappenden P, MacCabe JH, Robinson S, et al
   Cost and health impacts of adherence to the National Institute for Health and Care Excellence schizophrenia guideline recommendations.
   Br J Psychiatry. 2020 Dec 14:1-6. doi: 10.1192/bjp.2020.
   PubMed     Abstract available
   
   
   November 2020
3. BRENNAN D
   Sarcosine in the management of schizophrenia.
   Br J Psychiatry. 2020;217:653.
   PubMed    
   
   
   
4. CURTIS D
   Author's reply.
   Br J Psychiatry. 2020;217:653.
   PubMed    
   
   
   October 2020
5. HEINZE K, Barron HC, Howes EK, Ramaswami M, et al
   Impaired inhibitory processing: a new therapeutic target for autism and psychosis?
   Br J Psychiatry. 2020 Oct 23:1-4. doi: 10.1192/bjp.2020.
   PubMed     Abstract available
   
   
   
6. BOGE K, Thomas N, Jacobsen P
   Is mindfulness for psychosis harmful? Deconstructing a myth.
   Br J Psychiatry. 2020 Oct 1:1-2. doi: 10.1192/bjp.2020.
   PubMed     Abstract available
   
   
   
7. FOND G, Pauly V, Bege T, Orleans V, et al
   Trauma-related mortality of patients with severe psychiatric disorders: population-based study from the French national hospital database.
   Br J Psychiatry. 2020;217:568-574.
   PubMed     Abstract available
   
   
   September 2020
8. LEMONDE AC, Joober R, Malla A, Iyer SN, et al
   Delusional content at initial presentation to a catchment-based early intervention service for psychosis.
   Br J Psychiatry. 2020 Sep 9:1-7. doi: 10.1192/bjp.2020.
   PubMed     Abstract available
   
   
   August 2020
9. CROSSLEY NA, Zugman A, Reyes-Madrigal F, Czepielewski LS, et al
   Structural brain abnormalities in schizophrenia in adverse environments: examining the effect of poverty and violence in six Latin American cities.
   Br J Psychiatry. 2020 Aug 18:1-7. doi: 10.1192/bjp.2020.
   PubMed     Abstract available
   
   
   
10. CASERAS X, Kirov G, Kendall KM, Rees E, et al
    Effects of genomic copy number variants penetrant for schizophrenia on cortical thickness and surface area in healthy individuals: analysis of the UK Biobank.
    Br J Psychiatry. 2020 Aug 14:1-8. doi: 10.1192/bjp.2020.
    PubMed     Abstract available
    
    
    
11. SALUJA N, Khurana H
    Letter to the editor about 'Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis'.
    Br J Psychiatry. 2020;217:458.
    PubMed    
    
    
    July 2020
12. MALLA A, Iyer SN, Rangaswamy T, Ramachandran P, et al
    Comparison of clinical outcomes following 2 years of treatment of first-episode psychosis in urban early intervention services in Canada and India.
    Br J Psychiatry. 2020 Jul 6:1-7. doi: 10.1192/bjp.2020.
    PubMed     Abstract available
    
    
    
13. CASETTA C, Oloyede E, Whiskey E, Taylor DM, et al
    A retrospective study of intramuscular clozapine prescription for treatment initiation and maintenance in treatment-resistant psychosis.
    Br J Psychiatry. 2020 Jul 1:1-8. doi: 10.1192/bjp.2020.
    PubMed     Abstract available
    
    
    June 2020
14. CHEN J, Chen R, Xiang S, Li N, et al
    Cigarette smoking and schizophrenia: Mendelian randomisation study.
    Br J Psychiatry. 2020 Jun 18:1-6. doi: 10.1192/bjp.2020.
    PubMed     Abstract available
    
    
    May 2020
15. OHI K, Shimada T, Kataoka Y, Yasuyama T, et al
    Genetic correlations between subcortical brain volumes and psychiatric disorders.
    Br J Psychiatry. 2020;216:280-283.
    PubMed     Abstract available
    
    
    March 2020
16. JANAWAY BM, Kripalani M
    Response letter to the article by Killackey et al (2019) 'Individual placement and support for vocational recovery in first-episode psychosis: randomised controlled trial'.
    Br J Psychiatry. 2020;216:167.
    PubMed    
    
    
    February 2020
17. PAKSARIAN D, Trabjerg BB, Merikangas KR, Mors O, et al
    Adolescent residential mobility, genetic liability and risk of schizophrenia, bipolar disorder and major depression.
    Br J Psychiatry. 2020 Feb 6:1-7. doi: 10.1192/bjp.2020.
    PubMed     Abstract available
    
    
    January 2020
18. FOLEY C, Heron EA, Harold D, Walters J, et al
    Identifying schizophrenia patients who carry pathogenic genetic copy number variants using standard clinical assessment: retrospective cohort study.
    Br J Psychiatry. 2020 Jan 22:1-5. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
19. OSIMO EF, Brugger SP, de Marvao A, Pillinger T, et al
    Cardiac structure and function in schizophrenia: cardiac magnetic resonance imaging study.
    Br J Psychiatry. 2020 Jan 9:1-8. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
20. LUYKX JJ, Stam N, Tanskanen A, Tiihonen J, et al
    In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine.
    Br J Psychiatry. 2020 Jan 8:1-8. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    December 2019
21. AMOS A
    Unsystematic review shows neither that early intervention in psychosis is cost-effective nor cost-minimising.
    Br J Psychiatry. 2019;215:744.
    PubMed    
    
    
    October 2019
22. DAVID AS
    Insight and psychosis: the next 30 years.
    Br J Psychiatry. 2019 Oct 18:1-3. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    September 2019
23. CURTIS D
    A possible role for sarcosine in the management of schizophrenia.
    Br J Psychiatry. 2019 Sep 10:1-2. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    July 2019
24. GAUGHRAN F, Stahl D, Stringer D, Hopkins D, et al
    Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort study.
    Br J Psychiatry. 2019 Jul 26:1-8. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
25. BEHAN C, Kennelly B, Roche E, Renwick L, et al
    Early intervention in psychosis: health economic evaluation using the net benefit approach in a real-world setting.
    Br J Psychiatry. 2019 Jul 24:1-7. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
26. CHAN SKW, Pang HH, Yan KK, Hui CLM, et al
    Ten-year employment patterns of patients with first-episode schizophrenia-spectrum disorders: comparison of early intervention and standard care services.
    Br J Psychiatry. 2019 Jul 9:1-7. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
27. CRAWFORD MJ, Huddart D, Craig E, Zalewska K, et al
    Impact of secondary care financial incentives on the quality of physical healthcare for people with psychosis: a longitudinal controlled study.
    Br J Psychiatry. 2019 Jul 5:1-6. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
28. ROSENHECK R
    The challenge of cost-effectiveness research on first-episode psychosis.
    Br J Psychiatry. 2019;215:386-387.
    PubMed     Abstract available
    
    
    June 2019
29. BECK K, Lally J, Shergill SS, Bloomfield MAP, et al
    Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis - ADDENDUM.
    Br J Psychiatry. 2019 Jun 10:1. doi: 10.1192/bjp.2019.
    PubMed    
    
    
    
30. PAPANASTASIOU E, Stone JM, Shergill S
    When the drugs don't work: the potential of glutamatergic antipsychotics in schizophrenia - ADDENDUM.
    Br J Psychiatry. 2019 Jun 10:1. doi: 10.1192/bjp.2019.
    PubMed    
    
    
    
31. LIU S, Li A, Liu Y, Yan H, et al
    Polygenic effects of schizophrenia on hippocampal grey matter volume and hippocampus-medial prefrontal cortex functional connectivity.
    Br J Psychiatry. 2019 Jun 6:1-8. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
32. LEGGE SE, Dennison CA, Pardinas AF, Rees E, et al
    Clinical indicators of treatment-resistant psychosis.
    Br J Psychiatry. 2019 Jun 3:1-8. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    May 2019
33. GUO C, He P, Song X, Zheng X, et al
    Long-term effects of prenatal exposure to earthquake on adult schizophrenia.
    Br J Psychiatry. 2019 May 22:1-6. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
34. GUO ZH, Li ZJ, Ma Y, Sun J, et al
    Brief cognitive-behavioural therapy for patients in the community with schizophrenia: Randomised controlled trial in Beijing, China - RETRACTION.
    Br J Psychiatry. 2019 May 21:1. doi: 10.1192/bjp.2019.
    PubMed    
    
    
    
35. DEL-BEN CM, Shuhama R, Loureiro CM, Ragazzi TCC, et al
    Urbanicity and risk of first-episode psychosis: incidence study in Brazil.
    Br J Psychiatry. 2019 May 17:1-4. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    March 2019
36. FORNARO M, Solmi M, Stubbs B, Veronese N, et al
    Prevalence and correlates of major depressive disorder, bipolar disorder and schizophrenia among nursing home residents without dementia: systematic review and meta-analysis.
    Br J Psychiatry. 2019 Mar 13:1-10. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
37. SOLMI F, Mascarell MC, Zammit S, Kirkbride JB, et al
    Polygenic risk for schizophrenia, disordered eating behaviours and body mass index in adolescents.
    Br J Psychiatry. 2019 Mar 6:1-6. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
38. PRIEBE S, Chevalier A, Hamborg T, Golden E, et al
    Effectiveness of a volunteer befriending programme for patients with schizophrenia: randomised controlled trial.
    Br J Psychiatry. 2019 Mar 4:1-7. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    February 2019
39. ZHUO C, Zhuang H, Gao X, Triplett PT, et al
    Lung cancer incidence in patients with schizophrenia: meta-analysis.
    Br J Psychiatry. 2019 Feb 26:1-8. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
40. GONG J, Luo C, Li X, Jiang S, et al
    Evaluation of functional connectivity in subdivisions of the thalamus in schizophrenia.
    Br J Psychiatry. 2019 Feb 22:1-9. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    
41. TOROUS J, Woodyatt J, Keshavan M, Tully LM, et al
    A new hope for early psychosis care: the evolving landscape of digital care tools.
    Br J Psychiatry. 2019 Feb 11:1-4. doi: 10.1192/bjp.2019.
    PubMed     Abstract available
    
    
    
42. XIANG B, Wang Q, Lei W, Li M, et al
    Genes in immune pathways associated with abnormal white matter integrity in first-episode and treatment-naive patients with schizophrenia.
    Br J Psychiatry. 2019 Feb 6:1-7. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    
43. COVENTRY P, Peckham E, Taylor J
    Promoting weight loss in people with schizophrenia: what do we still need to learn before implementing lifestyle interventions?
    Br J Psychiatry. 2019;214:74-75.
    PubMed     Abstract available
    
    
    January 2019
44. ACEITUNO D, Vera N, Prina AM, McCrone P, et al
    Cost-effectiveness of early intervention in psychosis: systematic review.
    Br J Psychiatry. 2019 Jan 30:1-7. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    December 2018
45. BROWN HK, Dennis CL, Kurdyak P, Vigod SN, et al
    A population-based study of the frequency and predictors of induced abortion among women with schizophrenia.
    Br J Psychiatry. 2018 Dec 20:1-8. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    November 2018
46. RICHARDS A, Horwood J, Boden J, Kennedy M, et al
    Associations between schizophrenia genetic risk, anxiety disorders and manic/hypomanic episode in a longitudinal population cohort study.
    Br J Psychiatry. 2018 Nov 26:1-7. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    October 2018
47. MAYER A, Hanlon F, Teshiba T, Klimaj S, et al
    An fMRI study of multimodal selective attention in schizophrenia - CORRIGENDUM.
    Br J Psychiatry. 2018 Oct 3:1. doi: 10.1192/bjp.2018.
    PubMed    
    
    
    September 2018
48. HOLT RIG, Gossage-Worrall R, Hind D, Bradburn MJ, et al
    Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial.
    Br J Psychiatry. 2018 Sep 25:1-11. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    
49. KILLACKEY E, Allott K, Jackson HJ, Scutella R, et al
    Individual placement and support for vocational recovery in first-episode psychosis: randomised controlled trial.
    Br J Psychiatry. 2018 Sep 25:1-7. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    
50. GUO ZH, Li ZJ, Ma Y, Sun J, et al
    Brief cognitive-behavioural therapy for patients in the community with schizophrenia: Randomised controlled trial in Beijing, China - Expression of Concern.
    Br J Psychiatry. 2018 Sep 17:1. doi: 10.1192/bjp.2018.
    PubMed    
    
    
    
51. CALAFATO MS, Thygesen JH, Ranlund S, Zartaloudi E, et al
    Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders.
    Br J Psychiatry. 2018;213:535-541.
    PubMed     Abstract available
    
    
    August 2018
52. DE SOUSA P, Sellwood W, Griffiths M, Bentall RP, et al
    Disorganisation, thought disorder and socio-cognitive functioning in schizophrenia spectrum disorders.
    Br J Psychiatry. 2018 Aug 24:1-10. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    
53. BULBENA-CABRE A, Bulbena A
    Schizophrenia and anxiety: yes, they are relatives not just neighbours.
    Br J Psychiatry. 2018;213:498.
    PubMed    
    
    
    
54. SOLMI F, Mohammadi A, Perez JA, Hameed Y, et al
    Predictors of disengagement from Early Intervention in Psychosis services.
    Br J Psychiatry. 2018;213:477-483.
    PubMed     Abstract available
    
    
    July 2018
55. OVIEDO-SALCEDO T, de Witte L, Kumpfel T, Kahn RS, et al
    Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM.
    Br J Psychiatry. 2018 Jul 10:1. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    
56. AJAYI D
    Our Most Troubling Madness: Case Studies in Schizophrenia across Cultures Edited by T. M. Luhrmann and Jocelyn Marrow. University of California Press. 2016. pound58.95 (hb), pound24.95 (pb). 304 pp. ISBN 9780520291089 (hb), 9780520291096 (pb).
    Br J Psychiatry. 2018;213:444.
    PubMed    
    
    
    June 2018
57. JACOBSEN P, Hodkinson K, Peters E, Chadwick P, et al
    A systematic scoping review of psychological therapies for psychosis within acute psychiatric in-patient settings.
    Br J Psychiatry. 2018 Jun 26:1-8. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    
58. SPENCER BWJ, Gergel T, Hotopf M, Owen GS, et al
    Unwell in hospital but not incapable: cross-sectional study on the dissociation of decision-making capacity for treatment and research in in-patients with schizophrenia and related psychoses.
    Br J Psychiatry. 2018 Jun 18:1-6. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    
59. MARWICK KFM, Stevenson AJ, Davies C, Lawrie SM, et al
    Application of n-of-1 treatment trials in schizophrenia: systematic review - ERRATUM.
    Br J Psychiatry. 2018 Jun 11:1. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    
60. FOND G, Boyer L, Berna F, Godin O, et al
    Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort.
    Br J Psychiatry. 2018 Jun 6:1-7. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    May 2018
61. MARWICK KFM, Stevenson AJ, Davies C, Lawrie SM, et al
    Application of n-of-1 treatment trials in schizophrenia: systematic review.
    Br J Psychiatry. 2018 May 10:1-6. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    April 2018
62. MACCABE JH, Sariaslan A, Almqvist C, Lichtenstein P, et al
    Artistic creativity and risk for schizophrenia, bipolar disorder and unipolar depression: a Swedish population-based case-control study and sib-pair analysis.
    Br J Psychiatry. 2018 Apr 26:1-7. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    
63. COLIZZI M, Murray R
    Cannabis and psychosis: what do we know and what should we do?
    Br J Psychiatry. 2018;212:195-196.
    PubMed     Abstract available
    
    
    
64. MUSTONEN A, Niemela S, Nordstrom T, Murray GK, et al
    Adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis.
    Br J Psychiatry. 2018;212:227-233.
    PubMed     Abstract available
    
    
    March 2018
65. OVIEDO-SALCEDO T, de Witte L, Kumpfel T, Kahn RS, et al
    Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders.
    Br J Psychiatry. 2018 Mar 28:1-3. doi: 10.1192/bjp.2018.
    PubMed     Abstract available
    
    
    February 2018
66. VAN DEN BERG D, de Bont PAJM, van der Vleugel BM, de Roos C, et al
    Long-term outcomes of trauma-focused treatment in psychosis.
    Br J Psychiatry. 2018 Feb 7:1-3. doi: 10.1192/bjp.2017.
    PubMed     Abstract available
    
    
    January 2018
67. BRESSAN RA, Grohs GEM, Matos G, Shergill S, et al
    Hope or hype in the treatment of schizophrenia - what's the role of the physician?
    Br J Psychiatry. 2018;212:1-3.
    PubMed     Abstract available
    
    
    December 2017
68. POWER P
    Outcome and recovery in first-episode psychosis.
    Br J Psychiatry. 2017;211:331-333.
    PubMed     Abstract available
    
    
    November 2017
69. HALL J
    Schizophrenia - an anxiety disorder?
    Br J Psychiatry. 2017;211:262-263.
    PubMed     Abstract available
    
    
    October 2017
70. LALLY J, Ajnakina O, Stubbs B, Cullinane M, et al
    Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies.
    Br J Psychiatry. 2017 Oct 5. pii: bjp.bp.117.201475.
    PubMed     Abstract available
    
    
    
71. PILLINGER T, Beck K, Stubbs B, Howes OD, et al
    Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis.
    Br J Psychiatry. 2017 Oct 5. pii: bjp.bp.117.200907.
    PubMed     Abstract available
    
    
    
72. VAN DEN NOORT M, Bosch P, Lim S, Litscher D, et al
    Magnetic resonance imaging in first-episode psychosis.
    Br J Psychiatry. 2017;211:250.
    PubMed    
    
    
    
73. BORGWARDT S, Schmidt A
    Implementing magnetic resonance imaging into clinical routine screening in patients with psychosis?
    Br J Psychiatry. 2017;211:192-193.
    PubMed     Abstract available
    
    
    September 2017
74. LARKIN A, Hutton P
    Systematic review and meta-analysis of factors that help or hinder treatment decision-making capacity in psychosis.
    Br J Psychiatry. 2017 Sep 7. pii: bjp.bp.116.193458.
    PubMed     Abstract available
    
    
    
75. GREGORY A, Mallikarjun P, Upthegrove R
    Treatment of depression in schizophrenia: systematic review and meta-analysis.
    Br J Psychiatry. 2017 Sep 7. pii: bjp.bp.116.190520.
    PubMed     Abstract available
    
    
    July 2017
76. TOMASSI S, Tosato S, Mondelli V, Faravelli C, et al
    Influence of childhood trauma on diagnosis and substance use in first-episode psychosis.
    Br J Psychiatry. 2017 Jul 20. pii: bjp.bp.116.194019.
    PubMed     Abstract available
    
    
    
77. HAYES JF, Marston L, Walters K, King MB, et al
    Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014.
    Br J Psychiatry. 2017 Jul 6. pii: bjp.bp.117.202606.
    PubMed     Abstract available
    
    
    
78. TURKINGTON D, Spencer H, Lebert L, Dudley R, et al
    Befriending: active placebo or effective psychotherapy?
    Br J Psychiatry. 2017;211:5-6.
    PubMed     Abstract available
    
    
    June 2017
79. ZHUO C, Tao R, Jiang R, Lin X, et al
    Cancer mortality in patients with schizophrenia: systematic review and meta-analysis.
    Br J Psychiatry. 2017 Jun 8. pii: bjp.bp.116.195776.
    PubMed     Abstract available
    
    
    May 2017
80. TAKEUCHI H, Kantor N, Sanches M, Fervaha G, et al
    One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysis.
    Br J Psychiatry. 2017 May 18. pii: bjp.bp.116.186007.
    PubMed     Abstract available
    
    
    
81. FALKENBERG I, Benetti S, Raffin M, Wuyts P, et al
    Clinical utility of magnetic resonance imaging in first-episode psychosis.
    Br J Psychiatry. 2017 May 4. pii: bjp.bp.116.195834.
    PubMed     Abstract available
    
    
    
82. CATTS SV, O'Toole BI
    Reducing long-term antipsychotic use: a therapeutic dead end?
    Br J Psychiatry. 2017;210:368.
    PubMed    
    
    
    April 2017
83. HASSIOTIS A, Noor M, Bebbington P, Afia A, et al
    Borderline intellectual functioning and psychosis: Adult Psychiatric Morbidity Survey evidence.
    Br J Psychiatry. 2017 Apr 6. pii: bjp.bp.116.190652.
    PubMed     Abstract available
    
    
    
84. CHANG WC, Kwong VW, Lau ES, So HC, et al
    Sustainability of treatment effect of a 3-year early intervention programme for first-episode psychosis.
    Br J Psychiatry. 2017 Apr 6. pii: bjp.bp.117.198929.
    PubMed     Abstract available
    
    
    
85. BHAVSAR V
    EMDR Therapy for Schizophrenia and Other Psychoses.
    Br J Psychiatry. 2017;210:304.
    PubMed    
    
    
    
86. SAMARA M, Leucht S
    Clozapine in treatment-resistant schizophrenia.
    Br J Psychiatry. 2017;210:299.
    PubMed    
    
    
    
87. WOOD SJ
    Autism and schizophrenia: one, two or many disorders?
    Br J Psychiatry. 2017;210:241-242.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: